Abstract: Eosinophils are a minority subpopulation of leukocytes whose roles in host defense against infection remain controversial, but which have been implicated in the pathogenesis of both acute allergic inflammation and the chronic bronchopulmonary remodelling in asthma. Eosinophilia, a hallmark of both helminth infections and atopic diseases, is maintained through upregulation of eosinophilopoiesis by means of increased production and effectiveness of Interleukin-5 (IL-5), a major Th2 cytokine. These mechanisms are further modulated by a wide variety of agents, including glucocorticoids, nonsteroidal antiinflammatory drugs and mediators of inflammation. We review recent progress made by different groups in the study of eosinophilopoiesis that led to the identification of the heterogeneous targets for developmental regulation by IL-5 and other agents, and to the ongoing characterization of the molecular mechanisms that ensure their commitment to the eosinophil lineage. We argue that the study of eosinophilopoiesis provides insight into basic developmental processes, and especially into how modulators influence the constitutive rate of eosinophil production by controlling the rates of apoptosis and terminal differentiation. The mechanisms underlying the apparently paradoxical effects of dexamethasone, a drug widely employed to control inflammation, as well as the role of specific molecular targets (including inducible NO synthase and CD95/Fas) in developmental regulation, are discussed in detail. We further argue that eosinophilopoiesis offers unique insights of how immune and endocrine effector loops interact to control both the steady-state responses to IL-5 and the susceptibility to modulation of these responses by drugs and cytokines. We also review the existing evidence on the recruitment of circulating stem cells and progenitors into inflammatory sites, and on a critical role for IL-5 in the accumulation of eosinophil lineage-committed progenitors in lungs of allergic mice. Finally, we review recent progress in the study of the regulatory T cell populations present in bone-marrow, and discuss alternative mechanisms through which cellular immunity may influence eosinophilopoiesis.
PURPOSE AND SCOPE OF THIS REVIEW
The purpose of this review is to discuss work by several groups, concerning the intersections between three kinds of biological processes that are usually dealt with separately: namely, development, immunity and the mechanisms of antiinflammatory drug action, as highlighted by the specific context of eosinophilopoiesis. As detailed below, some studies have provided evidence that various anti-inflammatory drugs modulate eosinophil differentiation in a lineage-specific manner. Other studies provided evidence that the immune status of an animal decisively influences its ability to respond to some of these drugs. We further discuss how both classes of phenomena may be related to the underlying cellular mechanisms of cell differentiation and apoptosis. We believe these phenomena are of interest to the Journal's readership because, although potentially important, the possibility of such interactions has been hitherto overlooked in pharmacological studies.
EOSINOPHILOPOIESIS AS PART OF A BIOLOGICAL PUZZLE
Over a century after Paul Ehrlich's original description, eosinophil granulocytes remain the subject of intense research and great curiosity [1] [2] [3] . As in the case of mast cells, also described by Ehrlich, their roles in immunopathology remain better known than their contribution to host defense [4] [5] . Working together, IgE antibodies, mast cells, and eosinophils achieve, upon exposure to airborne antigens, fast modulation of vascular capacitance and permeability, stimulation of sensory *Address correspondence to this author at the Dept. of Immunology, Instituto de Microbiologia Prof. Paulo de Góes, Federal University of Rio de Janeiro, Centro de Ciências da Saúde-Bloco I, 2nd. floor, Room 066, Avenida Carlos Chagas Filho 373, Cidade Universitária CEP. 21941-902, Rio de Janeiro, Brazil; E-mail; pxelsas@yahoo.com.br nerve endings, contraction of smooth muscle in the airways, promotion of mucus secretion by goblet cells and generation of a specific type of inflammatory infiltrate, rich in eosinophils and basophils [6] [7] [8] . In the long run, chronic eosinophilic infiltration of the airways and damage to bronchial epithelium inflicted by eosinophil-derived cytotoxic proteins may lead to long-lasting bronchopulmonary hyperreactivity, and long-term airways remodelling, both central features of asthma [9] [10] [11] [12] . Also, in the idiopathic hypereosinophilic syndromes, a class of uncommon chronic diseases characterized by very high eosinophil counts in blood and tissues [13; see 14 for a comprehensive account], serious damage to the heart and peripheral nervous system, which is difficult to control, is ascribed to the cytotoxic effects of proteins released by the large pool of circulating eosinophils, many of which seem to be spontaneously activated.
Like mast cells, eosinophils are found in widely divergent vertebrate species [15] , suggesting they provide some survival advantage to the organism. Mast cells have been recently shown to be important in the early stages of response to bacterial infections [16, 17] , and to mediate communication between the immune system and the brain [18] . Similarly, IgE has been shown in genetically deficient models to be primarily required to prevent progressive autoinflammatory damage to the lungs [19] . Together, such findings support the notion that the components of the mast cell-basophil-eosinophil axis may serve novel functions, not necessarily related to the potent proinflammatory effects detectable when they are added to the system, rather than removed from it.
Many important roles have been proposed for eosinophils [2] . Eosinophils are believed to provide a significant line of defense against helminth infection, because eosinophilia is a hallmark of worm infestations in humans and other vertebrate species [20, 21, 15] . They contain an extensive array of potentially injurious molecules which are stored in cytoplasmic granules and extruded in response to ligation of surface (especially Fc) receptors [2] . This putative effector function is, however, difficult to study in vivo, where it might be most relevant; alternatively, the different in vitro models in which eosinophils have been shown to kill parasites can be criticized on the grounds of the artificiality of the necessary conditions, especially the high effector-to-target ratios, and the time it takes for worm killing to occur; also, only some worm species or some developmental stages for a certain species are killed [20] [21] . As many worms are known to subvert host defenses [22, 23] , the eosinophilia of helminth infections could equally serve the survival strategies of the parasite. The studies showing protection by eosinophils against A n g i o s t r o n g y l u s cantonensis infection [24] have the limitation of using a nonpermissive host species. For most other worm infections, no such protective effect has been shown, and eosinophilia in the presence of persistent infection is the rule.
Eosinophils are mobile and have a relatively long life in tissues [2] , into which they migrate following selective chemoattractant gradients and using specialized adhesion molecules such as α4β1 integrin (VLA-4) [2, 25] . They have been been shown to produce many cytokines, comprising those classically associated with the Th1 and Th2 profiles, as well as those implicated in tissue repair [2, 26] . They also interact with T lymphocytes, presenting a variety of antigens in secondary responses [2] . In addition, eosinophils are an important source of lipid mediators of inflammation, including leukotrienes, prostaglandins and Platelet-Activating Factor; finally, they have also been reported to produce a large variety of neuropeptides [2, 26] . Eosinophils are certainly sensitive to a great variety of contexts, due to their expression of receptors for cytokines, chemokines, glucocorticoids, prostanoids, cysteinyl-leukotrienes (Cys-LT), Platelet-Activating Factor, chemotactic peptides, neuropeptides, neurotransmitters, histamine, ATP, purines, extracellular matrix components, adhesion molecules, and microbial components, among others [2, 26] . They are therefore likely to play a regulatory role (as opposed to an effector role) in some context. Accumulating evidence indicates that they play different regulatory roles not only in the innate and acquired immune responses, but in the reproductive system and during development as well, including the development of the T cell repertoire in the thymus [2] .
Much of the best evidence available on the regulatory functions of eosinophils, however, concerns their role in the late events of allergic lung inflammation in mice (development of airway hyperreactivity to a wide variety of stimuli, and airway remodeling with hypertrophy of smooth muscle, metaplasia in goblet cells and increased deposition of extracellular matrix), which reproduces similar processes in human asthma [27, 28] . Until recently, most studies targeted the cytokines that support eosinophilopoiesis (the production of eosinophils in bone-marrow and other sites): Interleukin-5 (IL-5), secreted by Th2 lymphocytes, mast cells, basophils and eosinophils themselves, is considered the major eosinophilopoietic factor in vivo [2, [29] [30] [31] [32] , hence targeting IL-5 is a favored strategy.
IL-5, Interleukin-3 (IL-3) and Granulocyte-macrophage colony stimulating factor (GM-CSF) form a family of hemopoietic cytokines coded for by linked genes (located in chromosome 11 in mice, and chromosome 5 in humans). All three bind to specific receptors, composed of two chains, α and β. The α chain recognizes specifically the ligand, but does not transduce signals; the β chain transduces signals in response to occupation of the receptor, but has no ligand specificity. The same β chain is found in the composition of the three distinct receptor classes, and is therefore known as common β (βc) chain [2, 33] . The three receptor classes are expressed in different subsets of cells, with some overlapping, including expression of all three in eosinophils. Their intracellular signalling mechanisms are very similar, as expected from the existence of a single, common transducer element [33] . Accordingly, all three are able to stimulate eosinophil production both in vivo and in vitro [2] ; one might therefore expect eosinophilopoiesis to be similarly promoted by any of the three cytokines. Nevertheless, the accumulated evidence supports an essential role for IL-5 in eosinophilopoiesis, which is not compensated by IL-3 or GM-CSF [29] [30] [31] [32] , which nevertheless behave as a c c e s s o r y eosinophil growth factors that can synergize with IL-5 to achieve lineage-selective stimulation [2, 33] . The possible reasons for these differences in activity include the existence, at least in mice, of an alternative signaling pathway, employing an IL-3Rα-selective β chain, another product of the same gene family as βc [32] ; other factors might include cytokine-induced crossregulation of receptor expression among the βc binding cytokines, and the expression of multiple receptor isoforms [33] .
Hence, neutralizing (TRFK-5) antibodies specific for IL-5 were often used to assess the contribution of eosinophils to the chronic structural and functional changes of the lungs in experimental models of asthma. However, published studies based on this approach include both some supporting and some refuting an essential role for IL-5 and eosinophils in airway hyperreactivity [12, 30] , thereby adding to the uncertainty in this field [34] . Possible reasons include: a) anti-IL-5 antibodies have many other effects (for instance, on B cells) in addition to reducing eosinophilia; b) they might be less effective in eliminating tissue eosinophils than originally expected. For instance, eosinophil production proceeds (even though at a much lower rate) when all influence of IL-5, or of βc-mediated signalling, has been rigorously ablated [31] . This has been interpreted as evidence that additional eosinophilopoietic cytokines exist [32] ; and there is evidence that supports a secondary role for eotaxin in the maintenance of eosinophil numbers in blood and tissues [35] .
All this has nevertheless prompted research on a system that would be free of eosinophils but not of IL-5. Two transgenesis strategies have recently been adopted to achieve this goal: a) the generation of transgenic mice which express a construct containing the open reading frame for the Diphteria Toxin A chain (DTA) under the control of a promoter sequence taken from the eosinophil peroxidase gene, thereby ensuring the lineage-restricted expression of a suicide factor [27] ; b) the specific gene targeting for a particular regulatory site (palindromic GATA-1 site of the downstream promoter region) of the gene coding for the GATA-1 transcription factor, which has been implicated in eosinophil development [28] . Importantly, eosinophil deficient mice harboring the palindromic GATA-1 deletion are susceptible to the development of airway hyperreactivity to the same extent as wild-type controls; however, they present greatly decreased airway remodelling [28] . The results of this study suggest that eosinophils might well be innocent of inducing airway hyperreactivity, but guilty of promoting airway remodelling. However, the study with transgenic DTA expression in the eosinophil lineage supports the notion that eosinophils also contribute to airway hyperreactivity [27] .
The findings with GATA-1 mutant mice raise the interesting possibility that eosinophils play some role in tissue repair and wound healing, which are closely related to airway remodelling [36] . Eosinophils are an important cellular component of healing wounds in those species where their presence was examined [37, 38] , and secrete the transforming growth factors-α (TGF-α ) and -β 1 (TGF-β 1) [39] . However, eosinophil depletion in hamsters using TRFK-5 antibodies accelerated wound healing, thereby suggesting that eosinophils contribute to retard wound healing [38] , through some hitherto undefined mechanism.
Below, we review some of the current evidence about eosinophilopoiesis, including some of our own studies that also link eosinophils to surgical wounds [40] , hoping to contribute to the ongoing debate on the physiological roles of eosinophils, for something can be learned about the value of a given cell type to the organism, from studying the conditions in which its development is fostered (or suppressed) by systemic influences, that presumably reflect the needs of the organism.
EOSINOPHILOPOIESIS AS A MODEL TO STUDY IMMUNE REGULATION OF DEVELOPMENT
Eosinophilopoiesis provides a privileged model for the study of the interactions between development and immunity. Eosinophils are easy to identify, and can be either eliminated or increased in the body without obvious harmful effects. Their production is controlled by a lineage-specific growth factor, IL-5; indeed, eosinophils are the only myeloid lineage in bonemarrow that depends, for both its steady-state maintenance and its enhanced production in response to infection, on intact βc signaling [31] . IL-5 thus provides the system with both its major driving force and its essential controlling element. Signaling through IL-5 receptors in eosinophils involves activation of tyrosine kinases (Lyn, Syk, and JAK2) which propagate through the Ras-MAPK and JAK-STAT pathways, leading to eosinophil differentiation from lineage-committed progenitors, or to increased survival in the case of mature eosinophils [41] . Most sources of IL-5 so far identified in the body are involved in adaptive immune responses [2] , even though keratinocytes may be recruited into IL-5 production in the presence of infection, through innate immune mechanisms [42] .
The interaction of the basic IL-5 signal with a variety of modulators provides further insight on the nature of lineage commitment, as well as on opportunities for systemic regulation of hemopoiesis, a process that is often regarded as dominated by short-range interactions with stromal cells [43, 31] . In the following sections, a number of observations are discussed, which combine systemic (immunization, challenge) and clonal (colony-formation assays) procedures, allowing us to address fundamental questions concerning the links between the fate of individual cells and the state of the entire organism. Furthermore, as eosinophil production is central to the pathogenesis of the hypereosinophilic syndromes, where management is not considered satisfactory [13, 44] , novel insights of how eosinophil population sizes are regulated might lead to improved treatment of these rare diseases. Eosinophils have alternatively been described as originating in cells committed only to their eosinophil lineage, or as sharing an immediate common ancestor with granulocytes and macrophages, or with basophils [45, 46, 8, 02] . Some understanding of the methods used to obtain this information, as well as of their limitations, is required for a critical evaluation of the findings.
Eosinophilopoiesis is difficult to study in situ, for eosinophils are a minority population, and in bone-marrow all hemopoietic lineages are represented as a continuum of maturation. Even though it is likely that bone-marrow consists of a series of specialized, neighboring microenvironments, most studies ignore any vivo compartment boundaries, and treat "bone-marrow" as a mixture of cells of more or less uniform composition. Eosinophilopoiesis is more easily analysed in an ex vivo culture, where single lineage stimulation is achieved by adding IL-5 (alone or in combination with synergistic concentrations of other factors), and where different targets (usually assumed to represent different stages with progressively restricted developmental potential) can be distinguished by seeding the culture in semisolid media (for clonal, progenitor or colony-formation assays) or liquid media (for differentiation, or precursor assays).
Until recently, progenitors and precursors for the myeloid lineages in the bone marrow were only defined operationally, that is, as a function of their behaviour in a given culture system, not necessarily as a function of something that can be unambiguously identified in vivo. Even though the accumulating information concerning expression of surface markers, growth factor receptors and signal transducing proteins is expected to make it possible to identify precursors without resource to cell culture, we have adhered to these definitions, which are based on fundamental cell properties, for the purposes of the following discussion. A progenitor gives rise to a colony in semisolid media after a certain period of culture in the presence of a given source of growth factors. A precursor is unable to form colonies, but gives rise to terminally differentiated progeny after a certain period of culture in the presence of growth factors (which may differ from those used in clonal assays). The ability to form colonies is a property shared by cells from bone-marrow with widely different characteristics; nevertheless, it is a very special property, as one observes at best a few hundred colonies, after seeding many thousands of bone-marrow cells. Because colony formation involves several division cycles, and because large numbers of cells may be present in some types of colonies (the so-called blastic colonies) [47] , most of the proliferative potential in bone-marrow is associated with the progenitor compartment, which, unlike stem cells, is not self-renewing and therefore depends on stem cells to be replenished. Identification of progenitors relies on the criteria used to define a colony, which may vary among studies. Colonies of lower proliferative potential (as compared to blastic colonies) are usually composed of cells that are differentiated enough to qualify as either precursors or mature cells. Such colonies are ascribed to lineage-committed progenitors, although only some are really committed to a single lineage. By contrast, blastic colonies contain cells which retain colony-forming ability, revealed by harvesting and dissociation of the original colony, followed by replating [47] . Secondary colonies obtained by this double cloning procedure usually conform to the lineage-committed pattern. The usual interpretation is that stem cells give rise to the high proliferative potential cells which originate blastic colonies, and the latter, sometime along their expansion, commit themselves to one or a few predictable fates. Once commitment has occurred, differentiation proceeds regardless of whether cells of a given lineage are pressed together in a colony, or free to settle where their closest neighbours will belong to other lineages.
With these limitations in mind, significant progress was achieved through the recent identification of lineage-committed eosinophil progenitors from murine bone-marrow as cells expressing the GATA-1 transcription factor at relatively low levels, along with the α chain of the IL-5 receptor (IL-5Rα) and the CD34 adhesion molecule [48] . These progenitors can be found at low frequencies among the progeny of those cells that give rise to both neutrophils and monocytes, in addition to eosinophils, the so-called granulocyte/monocyte progenitors. Growth and differentiation of eosinophils from lineagecommitted progenitors is driven by IL-5, and explains the occurrence of pure eosinophil colonies. Because cells along the entire sequence from granulocyte/monocyte progenitors through lineage-committed eosinophil progenitors to mature eosinophils respond to GM-CSF and IL-3, these findings also account for the ability of the latter factors to stimulate growth of both pure colonies and mixed colonies containing eosinophils, even in the absence of IL-5. Lineage-committed progenitors expressed low levels of the c-Kit receptor that responds to Stem Cell Factor (SCF), and presumably can still respond to SCF by proliferation and differentiation. This might be relevant to studies that show SCF as capable of stimulating the growth of colonies containing eosinophils [32] ; interestingly, if receptors for IL-5 could be absent (or inactivated; see, for instance, 49) while other elements of the eosinophil differentiation programme (as, for instance, GATA-1 and c-Kit) are present, this might explain why some SCFresponsive eosinophil progenitors seem insensitive to IL-5 [32] .
Detailed analysis of lineage derivation from granulocyte/monocyte progenitors pointed to an earlier separation of the monocyte and granulocyte lineages, with the consequence that colonies producing both neutrophils and eosinophils were found, but not colonies containing both monocytes and eosinophils [48] . Again, this is consistent with evidence for a progenitor common to the eosinophil and neutrophil lineages displaying receptors for both SCF and G-CSF [32] . The latter cytokine has many amplifying effects on hemopoiesis [50] , but is considered lineage-selective for neutrophils when present in progenitor assays. Its ability to amplify the eosinophil colony growth induced by SCF suggests that committment to eosinophil differentiation may occur independently of the expression of IL-Rα, provided the cell is helped out by SCF. In progenitor assays carried out with G-CSF alone, such SCF-dependent, IL-5-insensitive targets would not be detected, and only neutrophils would form.
While these recent findings are enlightening in many respects, a number of observations from the literature remain difficult to incorporate into the emerging picture. Foremost is the evidence that eosinophils and basophils share an immediate common ancestor, and that both cell types develop under the influence of IL-5, which has been advanced by several groups [51, 52, 02] . The isolation of lineage-committed eosinophil progenitors has shown that these do not express a number of markers associated with the basophil and mast cell lineages [49] , the latter being regarded as having a common origin with basophils [8] . Hence, if a single common progenitor exists, separation of the eosinophil and basophil lineages likely occurs before commitment can be evidenced by the simultaneous expression of IL-5Rα and GATA-1.
Progenitor studies are favored in much of the research on hemopoiesis, because of their apparent relationship to lineage committment. However, commitment has no causal relationship with colony formation (in blastic colonies, by definition, lineage committed cannot be detected), and differentiation of eosinophils can be studied in liquid culture conditions [53] . In this case, information about how many lineage-committed cells are present in bone-marrow can still be obtained by limiting dilution assays [48] ; as expected, the distinction between progenitors and precursors becomes blurred. Importantly, by choosing to enumerate progenitors (by colony counts or limiting dilution assays), the investigator emphasizes the frequency of committed cells, rather than the size of the progeny that will come from them. With this approach, modulators that enhance eosinophil progenitor commitment can indeed be demonstrated. However, it is clear that the progeny size from a committed cell also offers major opportunities for lineagespecific regulation, even when the number of committed cells does not change [54] .
This complex picture can be summarized for the eosinophil lineage in Fig. (1) , where the relative size and phenotype of the different hemopoietic cell populations can be seen, along with the relative importance of changes in commitment versus population size in determining the outcome for each phase.
Transcriptional regulation is a major mechanism of specification of hemopoietic lineage [55] . Because the eosinophil has a specialized repertoire of granular proteins, which are expressed exclusively (or almost) in this lineage [2] , the analysis of sequences common to the promoter regions of the corresponding genes points to transcription factors which might be involved in the coordinated expression of these genes -thereby underlying the acquisition and maintenance of an eosinophil phenotype, hence differentiation. This analysis has pointed to GATA-1, CCAAT/enhancer binding protein (C/EBP) and RFX as possible regulators of eosinophil-specific gene expression [55] .
Further evidence that commitment to the eosinophil lineage (which, by definition, precedes differentiation) is equally determined by the pattern of expression of these genes was obtained by a variety of approaches. In chicken transformed hemopoietic cell lines, differentiation into eosinophils was induced by enforced expression of C/EBP and GATA-1 [55] . It became clear that quantitative changes in expression of GATA-1 substantially altered its ability to induce commitment to the eosinophil lineage, for moderate amounts of GATA-1 were required for eosinophilopoiesis, but high levels of GATA-1 inhibited it [55] . In humans and mice, it is clear that the patterns of transcription factor expression and activity during neutrophil and eosinophil development present important similarities; for instance, enforced expression of C/EBP in human CD34+ myeloid progenitor cells promotes both eosinophil and neutrophil development [55] . Furthermore, C/EBP-deficient mice show a selective block in the development of both eosinophils and neutrophils [55] . Again, both observations are fully consistent with the origin of both lineages in an immediate common ancestor [49] .
GATA-1 expression, however, is closely associated with eosinophil commitment. For instance, bone-marrow cells from transgenic mice bearing a reporter construct consisting of the enhanced green fluorescent protein coding sequence under the control of a promoter sequence derived from the GATA-1 gene, which can be used to monitor the activity of the endogenous GATA-1 gene, will produce green fluorescent colonies consisting exclusively of eosinophils, when cultured in the presence of IL-5 [55] . This is conceptually important: if other GATA-1 expressing cells (like mast cell progenitors) were capable of responding to IL-5, green fluorescent colonies containing cells other than eosinophils should be detected as well.
The effect of enforced expression through retroviral transduction of GATA-1 in human CD34+ progenitors expanded from cord blood by culture in cytokine mixtures provided further evidence of a causal role for GATA-1 in eosinophil commitment: cells transduced with either GATA-1 or GATA-2 and further stimulated with SCF and GM-CSF produced almost exclusively eosinophil colonies; without such transduction, the same cells would produce mostly granulocyte-and macrophage-containing colonies.
This dramatic increase in commitment was not accompanied by an increase in the total number of colonies formed in these conditions [55] , confirming that commitment, detectable as a change in the frequency of a given progenitor type, can be enhanced without an expansion in total progenitor numbers [48] .
Conversely, specific interference with GATA-1 or GATA-2 expression and function by retroviral transduction of constructs coding for dominant-negative forms of GATA-1 prevented the growth of human eosinophil precursors in the presence of IL-5 [55] , showing that expansion driven by IL-5 is highly dependent on expression of GATA-1 and GATA-2.
Even though GATA-1 and GATA-2 factors have such a specific effect on eosinophil development when conditions are designed to circumscribe their action, they play a variety of 
1). The different ways and targets of regulation in eosinophilopoiesis.
The different developmental compartments where regulation has been described (hemopoietic stem cells/HSC, blastic colony-forming progenitors, lineage-committed progenitors, lineage-specific precursors, and mature eosinophil pool of the bone-marrow) are separately depicted. Regulation which can be achieved independently of an increase in cell numbers within the compartment (for instance, through a change in the rate of commitment, or of asymetric cell division in the case of the selfrenewing HSC) is shown as horizontal gradients. Regulation which depends on cell multiplication within the compartment is shown as vertical gradients. Positive and negative regulation therefore correspond to expansion or contraction of the gradients, respectively. The arrows allow one to follow the progeny of a single HSC through all these compartments, highlighting how a small change in development can be considerably amplified at subsequent steps. No such descent relationship is depicted between the cells in the mature cell pool and the cells in the lineagecommitted precursor compartment, because the former represent the terminally mature stages, rather than the offspring, of the latter. In the mature cell pool, which is incapable of proliferation, regulation is achieved through changes in the rates of cell death.
other roles in hemopoiesis: mice bearing a mutant GATA-1 gene which is expressed at low levels under an erythroid lineagespecific promoter have greatly reduced definitive erythropoiesis and megakaryocytopoiesis, in a way consistent with the pattern of GATA-1 expression by cells of both lineages in healthy mice.
Because the GATA-1 gene is located in the X chromosome, all male fetuses bearing the mutation fully express the GATA-1 deficient phenotype, which includes a complete lack of IL-5-responsive eosinophil progenitors. Transgenic expression of either GATA-1 or GATA-2 on this mutant background was able to rescue eosinophil development, along with variable improvement of the erythroid deficiency [55] . It can therefore be asked why the expression of a factor that plays various important roles in several hemopoietic lineages may appear to be so decisive for eosinophils. This probably reflects more than one mechanism, including: a) an absolute dependency of eosinophil commitment on GATA-1, which cannot be compensated for by endogenous expression of GATA-2 in GATA-1 deficient animals (despite the effectiveness of GATA-2 in a variety of transfection and transduction approaches); b) an eosinophil-specific pattern of GATA-1 activation and expression; c) a context specified by a particular combination of other transcription factors that renders the activity of GATA-1 effective in inducing the eosinophil phenotype (as, for instance, C/EBP, which specifies a more general granulocyte commitment, and PU.1, which specifies a myeloid, as opposed to a lymphoid, cell fate).
Evidence for these different mechanisms has been obtained in several studies. For instance, it is clear that the GATA-1 gene can be transcribed in several different ways, as different regulatory regions have been identified that direct transcription from different start sites, depending on the cell lineage examined. In erythroid cells, transcription relies on more than one regulatory region, and therefore resists mutations that can ablate transcription in megakaryocyte progenitors. The continuity of transcription, in this case, was shown to depend on a high-affinity palindromic ("double") GATA-1 site, which is thought to respond to the presence of the transcription factor by amplifying its transcription. Conversely, the inactivation of this palindromic site, by itself, does not eliminate erythropoiesis, provided the regions that normally serve erythroid-and megakaryocite-specific transcription are preserved; however, it completely prevents the development of the eosinophil lineage, thereby showing that eosinophils use lineage-specific mechanisms of transcription and activation of GATA-1 [56] . As a corollary, mice deficient in this palindromic site have proven very useful tools in eosinophil research [28] , because they do not present the erythrocyte and megakaryocyte deficiencies that result in fetal death of the original GATA-1-deficient mice.
A further evidence of the specificity created by this regulatory site is that it is present in a number of GATA-1-regulated genes which are selectively expressed in eosinophils, including those coding for Major Basic Protein (MBP, one of the most important of the eosinophil granule cytotoxic proteins), the α chain of the IL-5 receptor and the CCR3 receptor [02] . Transcription of the MBP gene is synergically induced by the combination of GATA-1 and PU.1 transcription factors, in the presence of C/EBP [57] ; this is a highly specific interaction, as GATA-1 and PU.1 most often were reported to antagonize each other's actions [02] , suggesting that GATA-1 in eosinophils is working in a unique molecular environment, and achieving different effects than it would elsewhere.
The dramatic impact of transcription factor levels on the commitment and differentiation of progenitors into the eosinophil lineage, as well as the decisive role played by GATA-1 and C/EBP, have led to the proposal that eosinophils are made "by subtle shifts in transcription factor expression" [58] , that is, "eosinophil" would be better defined as a state, or p h e n o t y p e , specified by a given balance of selected transcription factors, rather than a unique cell lineage. It left open the possibility that eosinophils might have multiple origins, arising whenever the proper shifts in transcription factor activity were allowed [58] . Accordingly, separate origins from a granulocyte-macrophage progenitor (corresponding to that described in [49] ), or from a megakaryocyte-erythroid progenitor, and even from a more primitive, common myeloid progenitor, were contemplated; significantly, even this very comprehensive model did not include the eosinophil-basophil progenitor, which has been proposed in different studies [2] , including some in which transcription factor levels were directly manipulated [58] . This leaves to future studies the important task of clarifying which differences in experimental conditions could account for such divergent results.
A central issue is whether IL-5, the essential chemical link between immunity and development, provides instructive signals that lead to commitment, or whether it selects and expands committed cell populations. IL-5Rα is expressed in lineage-committed eosinophil progenitors, EoPs, but not in the vast majority of granulocyte-macrophage progenitors [49] . Most importantly, however, granulocyte-macrophage progenitors expressing IL-5Rα as a result of retroviral transduction became capable of colony formation in the presence of IL-5 (which was ineffective in nontransduced controls). The colonies formed contained granulocytes, macrophages or both, but not eosinophils [49] . This shows that I L -5 R α can be expressed in a noneosinophilic myeloid progenitor and deliver growth and differentiation signals, leading to neutrophil and macrophage production. However, it does not do so in physiological conditions because it is not expressed in granulocyte-macrophage progenitors. Similarly, in transgenic mice expressing IL-5Rα in other hemopoietic lineages are studied, IL-5 can be shown to promote growth of various types of myeloid progenitor [60] . All this suggests that IL-5Rα expression is the result, not the cause, of eosinophil lineage commitment.
Once expressed, however, IL-5Rα stimulation might stabilize the eosinophil phenotype, by promoting the synthesis of eosinophil-specific gene products: by microarray analysis of bone-marrow cells from wild-type and IL-5-deficient mice, before and after infection with Schistosoma mansoni, increased expression of eosinophil-specific proteins was observed, requiring both the integrity of IL-5 signaling and the presence of the worms [61] . Interestingly, eosinophil-related chemokine receptors (CCR1, CCR3) were not induced, even though CCR3 activation induces eosinophil differentiation in concert with IL-5 [62] . Also, the GATA and C/EBP transcription factor expression was unaffected by IL-5, as expected from their progressive decline in expression once commitment is over and differentiation proceeds [49] .
The ability of IL-5 to support eosinophilopoiesis by sustaining proliferation and inducing terminal differentiation is paralleled by its ability to increase survival of mature eosinophils. The activation of specific signaling pathways, such as the Lyn tyrosine kinase, underlies both phenomena [63] . Understanding how IL-5 drives eosinophilopoiesis is essential for the proper evaluation of its interactions with environmental signals. IL-5 induces the proliferation, differentiation and survival of committed cells; the agents that act by modulating these cellular processes depend on IL-5 to exert their effects. By contrast, the modulators which affect the fundamental process of lineage commitment affect eosinophilopoiesis independently of IL-5.
THE IMPACT OF ALLERGEN CHALLENGE ON EOSINOPHILOPOIESIS
Eosinophilia has long been viewed as reflecting increased production of IL-5, as in worm infection or in transgenic mice overexpressing IL-5 [2, 45] . However, we provided evidence for increased effectiveness of IL-5 as an alternative means of enhancing eosinopoiesis [53] . In ovalbumin-sensitized BALB/c mice, allergen sensitization by itself had no significant effect on bone-marrow eosinophilia relative to non-sensitized controls, which had been exposed to alum alone. By contrast, intranasal allergen challenge of previously sensitized mice increased significantly the numbers of eosinophils in the bonemarrow relative to unchallenged as well as non-sensitized controls, when counts were performed 24 h after challenge. Challenge was effective only if animals had been previously sensitized. More importantly, bone-marrow from allergenchallenged, sensitized mice gave a much stronger response to eosinopoietic cytokines than that of unchallenged, sensitized controls [48] . Firstly, the yield of eosinophil colonies elicited in the presence of IL-3 was greatly increased, as soon as 2 h after allergen challenge. By contrast, total colony numbers were not significantly affected, highlighting the lineage selectivity of the effect. Secondly, the response of bone-marrow from challenged, sensitized mice to IL-5 in a precursor assay was also greatly enhanced. Differences in response were observed, in both cases, when cells were exposed to identical cytokine concentrations; by contrast, increasing the intensity of the stimulus did not eliminate the differences, which reflect the maximal effects in each experimental condition. Again, total bone-marrow cell numbers harvested from the donor mice were not significantly increased by allergen challenge, only the magnitude of their response to IL-5 was increased.
Hence, the changes in the eosinophil compartment in vivo (seen as bone-marrow eosinophilia) were paralleled by similar ex vivo changes in the ability to sustain i n c r e a s e d eosinopoiesis in response to an unchanged intensity of stimulus. Even though eosinophilia at day 0 as assessed in uncultured bone-marrow and eosinophilopoiesis as reflected in the response to IL-5 measured after 7 days in culture were increased in parallel, they should not be considered equivalent, and provide complementary information, instead. Eosinophilia is dependent on eosinophilopoiesis, but it also depends on the rate of exit of eosinophils from bone-marrow (provided that the rate of reentry is assumed as either negligible or nonexistant), as well as on the lifespan of cells inside the bone-marrow.
Upregulation of bone-marrow eosinopoiesis by airway allergen exposure still has many unexplained aspects. The nature of the decisive event originating in the airways that will eventually affect the bone-marrow, which is a distant target organ, remains to be determined. The short delay between the challenge and the upregulation of eosinophilopoiesis suggests a diffusible mediator acting systemically between the lungs and bone-marrow. Because the sensitization protocol used favors IgE formation, mediators released from IgE-bearing mast cells and/or basophils following cross-linking of specific IgE by ovalbumin might play a role, especially since it there is evidence that upregulation of bone-marrow eosinopoiesis following allergen exposure in humans is mediated by Cys-LT, on the basis of the effects of Cys-LT receptor antagonists on the bone-marrow [64] . Cys-LT are released from mast cells and basophils upon allergen challenge, and eosinophils themselves constitute an important source [65] . Cys-LT circulate and bind to receptors that are present in bone-marrow [66] . However, their release at the site of challenge might not result in sufficiently high systemic concentrations to ensure an effective local concentration in the bone-marrow. If this were the case, however, these extremely powerful autacoids would probably have evoked, while in transit, a number of untoward effects on the airways, microcirculation and cardiac performance [65] , before reaching the bone-marrow. While these objections may be raised against Cys-LT being the carriers of information from the challenge site to bone-marrow through the bloodstream, they do not exclude the possibility that Cys-LT could be produced inside the bone-marrow, in response to some other circulating factor released from the challenge site, a possibility which we discuss in more detail below.
We also assessed whether IL-5 itself played a causal role in augmenting the sensitivity of bone-marrow cells to its effects. The assumption, in this case, was that IL-5 could be important because it would: a) be rapidly released at the site of allergen challenge, from mast cells and/or Th2 lymphocytes; b) be able to enter the circulation, and rapidly reach distant sites including bone-marrow; c) be spared from degradation in the bloodstream; d) be effective at the distal site at very low molar concentrations. Furthermore, circulating IL-5 would have few or no systemic side effects, if compared with the Cys-LT, but would surely find its proper targets inside the bone-marrow. This hypothesis, nevertheless, would predict that: a) challenged and unchallenged animals should differ in the amounts of IL-5 released in their circulation following challenge; b) no endogenous source of IL-5 should be found in bone-marrow, thereby rendering the IL-5 in the bloodstream either accessory or irrelevant, by being closer to its targets, hence more concentrated. Evidence concerning the role of IL-5 is, at present, inconclusive, as the differences between challenged and unchallenged animals were not significant, with respect to the circulating levels of IL-5 after challenge, and as injection of TRFK-5 antibody decreased, but did not eliminate, the upregulation of bone-marrow responses following allergen exposure [53] . Interestingly, others reported that the number of cells producing IL-5 inside the bone-marrow was increased after allergen challenge [67] . This argues against a concentration gradient of IL-5 acting from its source in the challenge site into bone-marrow through the bloodstream; it suggests instead that IL-5-producing cells actively migrate from the challenge site to bone-marrow, thereby acting more effectively as carriers of information from one site to the other, for upregulation of IL-5 receptors was the main finding in bone-marrow of allergenchallenged humans [68] .
It would subsequently become clear that airway allergen challenge of sensitized mice would lead to the intrapulmonary accumulation of eosinophil lineage-committed progenitors, at the same time point (24 h) where increased capacity of response to IL-5 was shown in bone-marrow [69] . This indicates that several compartments capable of sustaining hemopoietic cells (the lungs, bone-marrow) are simultaneously affected by this one triggering event. In the case of the lungs, however, we could show a critical role for IL-5 in hemopoietic cell accumulation, as detailed below.
EXPECTATIONS AND FINDINGS: HOW GLUCOCORTICOIDS MODIFY THE OUTCOME OF IL-5 STIMULATION.
The idea that allergen exposure in the lungs reinforces eosinophil production in the bone-marrow of a sensitized host by generating a systemic signal was easily accepted, despite many gaps in our understanding, because it conformed to the popular view that allergens aggravate allergy by reinforcing its pathogenetic mechanisms. However, for glucocorticoids, which are often used to treat allergic diseases, suppression o f eosinophilopoiesis would meet expectations much better than enhancement. Many studies of glucocorticoid effects on eosinophilopoiesis (reviewed in 70), dating from the days before recombinant cytokines became available, had shown predominantly inhibitory effects, an important exception being the work of Barr and colleagues [71] , reporting that glucocorticoids stimulated eosinophil colony formation. When we addressed the issue of the interaction between recombinant cytokines and glucocorticoids in murine bone-marrow culture, however, dexamethasone strongly enhanced the eosinophil production driven by recombinant GM-CSF and IL-5 in semisolid and liquid bone-marrow culture, respectively [54] , thereby countering expectations, including our own. This enhancement was detectable as significant increases in the frequency of eosinophil colonies, as well as their size, and in the numbers of Eosinophil Peroxidase-positive (EPO +) cells produced in liquid culture. The effects were dose-dependent, detectable at low glucocorticoid concentrations, and blocked by the glucocorticoid receptor antagonist, RU486. The naturally occurring glucocorticoids, hydrocortisone (cortisol) and corticosterone, which participate in the endocrine response to stress in humans and mice, respectively, had the same enhancing effects. Glucocorticoids acted as modulators of IL-5 activity, but could not replace IL-5 as an eosinophil growth factor. Kinetics and other experiments provided evidence that glucocorticoids primed bone-marrow cells for increased proliferative responses to IL-5, and that the targets for this regulatory effect were early precursors, with later maturation stages being unaffected. In agreement with the proposed priming mechanism, administration of dexamethasone to naive animals did not cause bone-marrow eosinophilia, but did prepare bone-marrow cells for a greatly increased response to IL-5 upon subsequent culture. This was observed even when the in vivo dexamethasone exposure was as short as 2 h, reinforcing the idea that changes in the rate of commitment, resulting from two apparently unrelated treatments-glucocorticoid exposure and allergen challenge-can occur in this reduced time frame.
Much of our initial thinking about this finding revolved around the conditions which would allow such an interaction to take place, because dexamethasone is believed to suppress production of IL-5, among other cytokines [70; 72] . It could happen, nevertheless, if dexamethasone were introduced in a system in which IL-5 had already been induced, as is the case in a treatment setting; in this case, novel transcription would of the IL-5 gene would likely be suppressed, but previously synthesized IL-5 protein would still be able to act. By the combined effects of inhibiting IL-5 synthesis and enhancing the effects of preformed IL-5, dexamethasone might enhance eosinophilopoiesis for a limited period of time. This possibility gained in clinical interest when other groups reported similar observations with hemopoietic cells of human origin [52] .
Closer examination of the effects of dexamethasone in culture, however, shows that its mechanism of action is more complex than initially appreciated: murine eosinophils which matured in the presence of dexamethasone are often present in clusters containing large EPO+ cells of low granule density, and large, irregularly shaped nucleus with loose chromatin, which transmit an overall impression of cytological immaturity. They sharply contrast with the mature eosinophils produced in the presence of IL-5 alone, which are mostly single cells of uniform size, with a typical doughnut-shaped nucleus, rather uniform chromatin staining, and high density of EPO+ granules. Hence, dexamethasone actually primed bone-marrow eosinophil precursors for responding to IL-5 with increased production of EPO+ cells, but with decreased maturation of the surplus cells (which presumably implies decreased effector function as well). The extensive aggregation found in culture raises the additional question of whether these cells have reached a maturation stage in which they can dissociate from their partners inside the bonemarrow and enter the circulation. This observation raised the issue of how arrested maturation and cellular aggregation were related, and of the role played by glucocorticoids in both cellular responses.
APOPTOSIS AS A FINAL COMMON PATHWAY FOR REGULATING EOSINOPHILOPOIESIS
For both eosinophil and neutrophil granulocytes, apoptosis is believed to account for the controlled elimination of effete or damaged leukocytes from inflammatory sites [73] . Apoptosis can further be regarded as a powerful mechanism for regulating the numbers of cells that reach maturity. during normal development of eosinophils [74] .
We first became aware of the role played by apoptosis during eosinophilopoiesis when studying the effects of Prostaglandin E2 (PgE2). PgE2 dose-dependently inhibited production of eosinophils in IL-5-stimulated liquid bonemarrow cultures; reduction in EPO+ cell numbers was accompanied by the appearance of cells bearing the morphological hallmarks of apoptosis, including pyknosis, karyorrhexis and overall shrinking of the cell. These regressive changes affected only the eosinophils, as macrophages present in the same culture seemed very healthy, and indeed were often loaded with EPO+ granules, apparently originating in the uptake of EPO+ apoptotic bodies. Morphological evidence of apoptosis was accompanied by a variety of biochemical findings associated with apoptosis, including the fragmentation of nuclear DNA as detected by the TUNEL technique, the release of nucleosomal DNA in the extracellular medium, and the exposure of phosphatidylserine groups on the cell surface, indicated by the staining with Annexin V.
We interpreted these findings as evidence that PgE2 was able to selectively induce apoptosis after a cell had developed many of the morphological and cytochemical features of an eosinophil. This late-acting mechanism contributed to the ability of PgE2 to reduce the numbers of eosinophils produced in culture, independently of its ability to suppress the development of myeloid colonies (including eosinophil) in agar. Regulation by apoptosis of immature cells after commitment would represent a second, more specific level of control of eosinophilopoiesis by PgE2, quite apart from its previously described effects on myeloid colony formation, or from any possible effects on lineage commitment and precursor proliferative capacity [75] .
More importantly, the study of the proapoptotic effects of PgE2 would uncover a link between dexamethasone and apoptosis in developing eosinophils. Even though several studies had shown that dexamethasone and other glucocorticoids induce apoptosis in mature eosinophils, no apoptosis induction by dexamethasone was observed in IL-5-stimulated bone-marrow cultures [74] . Dexamethasone, however, was able to protect developing eosinophils from PgE2-induced apoptosis. The resulting eosinophils resembled those in cultures established with IL-5 alone, both in morphology and in numbers.
We were able to show that apoptosis induction by PgE2 depended on production of nitric oxide (NO) by the inducible isoform of NO synthase (iNOS): while PgE2 was ineffective in the presence of iNOS inhibitors, or on bone-marrow from iNOSdeficient mice, its effects were duplicated by NO donors in both normal and iNOS-deficient bone-marrow culture. The mechanism by which dexamethasone protected bone-marrow cells from apoptosis was, on the other hand, consistent with its ability to prevent induction of iNOS [72, 76] . This would indicate that iNOS-dependent apoptosis is one final common pathway for regulation of eosinophil numbers in culture, by agents that have opposite effects: by increasing iNOS expression, PgE2 induces apoptosis selectively in developing eosinophils; by decreasing iNOS expression, dexamethasone blocks PgE2-induced apoptosis selectively in the same cells.
It remains to be established whether or not dexamethasone is also able to interfere with the effects of NO donors, which would point to a secondary target downstream of iNOS. One possible downstream target for regulation of apoptosis in developing eosinophils has been identified in these studies: the CD95 (Fas)-CD95L (FasL) receptor-ligand pair.
Previous studies on mature eosinophils had suggested a role for apoptosis induction through the CD95/Fas death receptor pathway and for its attenuation by NO in the physiological regulation of mature eosinophil numbers as well as the increased survival of eosinophils from asthmatic patients [77] . In murine bone-marrow culture, PgE2 up-regulated expression of both CD95 and CD95L in developing eosinophils, which is suggestive of a role for this pathway in apoptosis induction [74] . Consistently with this hypothesis, neither PgE2 nor a NO donor were effective in cultures from CD95L-deficient gld mutant mice [74] . These data suggest that CD95L (and presumably its receptor CD95 as well) is essential for the apoptotic response to PgE2, similarly to what had been shown for iNOS. However, the inability of NO donors to trigger apoptosis in bone-marrow cultures from gld mice shows that CD95 is located downstream from iNOS in this pathway. Furthermore, although CD95-CD95L and NO seem to play important roles in apoptosis of eosinophils in both settings, these are not necessarily the same in developing and mature eosinophils. In mature human eosinophils, CD95 is the effector molecule, and NO attenuates its ability to induce apoptosis; in developing murine eosinophils, CD95 is the effector molecule, but NO seems to lead to its activation in a CD95L-dependent way, possibly by increasing expression of CD95L.
At present, we cannot exclude that these conflicting observations reflect effects of NO at different concentration ranges, rather than stage-specific patterns of response to an identical stimulus. Several studies have pointed out that NO may have apparently opposite effects at low and high concentrations, especially on granulocyte apoptosis, which may be delayed or accelerated by NO, depending on the concentration range that one studies [78] . The first possibility would reinforce the view that context (i.e., a specific combination of environmental clues) modifies cellular response patterns to one specific agonist, as previously suggested by the studies with dexamethasone on the response to IL-5.
We have recently addressed the issue of the relationship between the cellular aggregation induced by dexamethasone in IL-5-stimulated bone-marrow cultures and the immature phenotype of the aggregated cells (Gaspar Elsas et al. , submitted). Initially, we have established that aggregation was: a) associated with the increased expression of α 4 integrins (both α4β1 and α4β7); b) undone by probes that interfere with two different α 4 integrin ligands, namely VCAM-1 and MadCAM. The dissociation experiments, which allowed us to identify the critical ligands, were carried out by establishing cultures with or without dexamethasone, and adding adhesiondisruptive agents at day 3, followed by further culture up to day 5. The design was chosen because the addition of the α 4 -specific probes at day 0 completely prevented eosinophil development, regardless of the presence of dexamethasone, as expected from an early, important role for α 4 integrins in hemopoiesis [79] . Dexamethasone exerts all of its actions that lead to enhancement of eosinophilopoiesis between days 0 and 3 [54] , which has been described as the critical interval for commitment to the eosinophil lineage [53] ; accordingly, addition of adhesion-disruptive agents at day 3 did not affect the proliferative response to dexamethasone, as far as EPO+ cell counts are concerned. It did, however, have a marked effect on the terminal differentiation of these cells, which resembled the mature eosinophils of control cultures. These findings suggest that α 4 integrins play at least two successive roles in eosinophilopoiesis: initially (days 0 to 3), they are necessary for the response to IL-5 (and possibly for its enhancement by dexamethasone, as well); later (days 3 to 7), they are necessary for keeping the cells in their immature state, from which they can be rescued by dissociation.
These studies further uncovered an unexpected interaction between a proapoptotic agent (PgE2) and an anti-apoptotic agent (dexamethasone). Alone, dexamethasone induces aggregation and keeps cells immature; by itself, PgE2 induces apoptosis; together, dexamethasone and PgE2 induce neither aggregation nor immaturity, but no apoptosis, either. Instead, eosinophils produced in the presence of both dexamethasone and PgE2 mature terminally as single cells, and therefore exhibit a phenotype that is not induced by either substance. On the one hand, the presence of PgE2 prevents the aggregation and immaturity induced by dexamethasone; on the other hand, the presence of dexamethasone prevents the apoptosis induced by PgE2. The interaction between these drugs was accompanied by changes in α4 integrin expression: the latter was enhanced by dexamethasone, but brought back to control levels by the addition of PgE2.
FROM LOCAL CHALLENGE TO SYSTEMIC REGULATION: HOW THE FATE OF INDIVIDUAL BONE-M A R R O W C E L L S I S I N F L U E N C E D B Y IMMUNOENDOCRINE PATHWAYS
The hypothesis that upregulation of bone-marrow eosinopoiesis by allergen challenge was the outcome of an immunoendocrine mechanism was supported by transfer experiments: plasma from sensitized donor mice challenged with ovalbumin (but not from saline-challenged, similarly sensitized, controls), collected 24 h after airway challenge, and transferred to syngeneic recipients was able to upregulate responses to IL-5 in liquid culture of bone-marrow taken from the plasma recipients 24 h after transfer (i. e., 48 h after the original airway challenge). Plasma transfer from the appropriate donor group was equally effective in upregulating responses in naive recipients and in sensitized ones, thereby replacing the effects of both sensitization and challenge, as though both steps led to the generation of either a single circulating mediator, or a set of synergic mediators found in the same plasma sample [53] .
Further evidence came from the study of mice submitted to surgical implantation of a pellet of heat-coagulated hen egg white (the so-called EWI mice), which present an important accumulation of eosinophils in the implant site. Because these mice produce anaphylactic antibodies to ovalbumin, an antigen contained in hen egg white, and because when challenged with ovalbumin they develop allergic pulmonary inflammation accompanied by the development of bronchopulmonary hyperreactivity, eosinophilia could, in principle, be accounted for by the strong Th2 response [80] . However, because surgery is usually associated with an acute stress reaction to tissue injury and anaesthesia, and because, in this model, it was associated with eosinophilia, we investigated whether eosinophil production would be affected by surgery, and whether any effects could resemble those described above for glucocorticoids. The prediction would be that effects due to glucocorticoid modulation of the bone-marrow would be detectable soon after surgery, while effects due to Th2 immunity would necessarily have a lag time, reflecting the development of the Th2 response itself. Also, an exclusive Th2 mechanism would require both surgery and the presence of an antigencontaining pellet of hen egg white; by contrast, a stress hormone-dependent mechanism would be detectable in mice submitted to surgery alone.
Our results could clearly show that these two different mechanisms of bone-marrow eosinophilia operate in different groups of animals in this model. Both implanted (EWI) and control ("sham-implanted", that is, simply operated without implantation of the egg white pellet) mice presented a significant increase in eosinophil numbers in the bone-marrow as soon as 24 h after surgery. This increase was maintained in both groups up to 15 days post-surgery, with EWI mice presenting significantly higher bone-marrow eosinophil counts at day 15. However, the two groups clearly diverged afterwards: sham-implanted mice could no longer be distinguished from nonoperated controls by day 30, while EWI mice presented persistent bone-marrow eosinophilia [39] .
In support of an immunoendocrine mechanism for the eosinophilia in sham-implanted mice, when donors were submitted to surgery and their plasma was collected 24 h after surgery, bone-marrow eosinophilia was induced in naive recipients by plasma transfer (unpublished observations).
Subsequently, however, we could demonstrate that bonemarrow eosinophilia in sham-implanted mice was due to a mechanism dependent on secretion of glucocorticoid hormones by the adrenal glands, by a number of criteria, namely: a) its blockade by the glucocorticoid receptor antagonist, RU486; b) its prevention by the glucocorticoid hormone synthesis inhibitor, metyrapone; c) its absence in mice that had been submitted to surgical removal of both adrenal glands, after their ability to release glucocorticoids during the adrenalectomy procedure had been ablated by pretreatment with metyrapone, with special care being taken to ensure complete recovery from the effects of metyrapone administration before the effect of adrenalectomy was assessed. On the other hand, any possible contribution of adrenergic mechanisms, which also make part of the stress endocrine reaction, was ruled out with the use of the appropriate blockers.
Bone-marrow eosinophilia was, in sham-implanted mice, associated with an increased responsiveness to IL-5 and GM-CSF in culture, which resembled the effects of dexamethasone exposure. Again, this was shown, by all three experimental approaches, to be dependent on adrenal glucocorticoid release.
Despite the essential involvement of glucocorticoid receptors in both cases, important differences exist between the effects of surgical stress and those of dexamethasone. Surgery, but not dexamethasone, did induce eosinophilia in the bonemarrow. In this respect, the effects of surgery are closer to those of sensitization/challenge than to those of dexamethasone, because surgery not only primes for increased responses to IL-5 ex vivo, but also supports increased eosinophilopoiesis in vivo.
Given that surgical trauma makes the bone-marrow produce an increased number of eosinophils through a glucocorticoiddependent mechanism, this might be of physiological relevance, in view of the association of eosinophils with healing wounds [37] [38] [39] ; one is tempted to speculate that there is an increased need for eosinophils in the postoperatory period, and that the stress reaction triggered by surgery includes the endocrine mechanisms that signal this increased demand to the bone-marrow.
To evaluate whether similar immunoendocrine mechanisms could explain how allergen exposure in sensitized subjects rapidly influences the bone-marrow, we used modifications of our original sensitization/challenge and transfer protocols, as follows: a) a modified plasma transfer protocol, in which plasma from ovalbumin-sensitized donors was transferred into RU486-pretreated recipients; b) a modified sensitization and challenge procedure, in which RU486 or its vehicle were administered before challenge. In both cases, the pretreatment with RU486 prevented the effects of allergen challenge on the bone-marrow of sensitized mice (manuscript in preparation). Interestingly, a similar mechanism may be operative in humans, because allergen challenge in asthmatic patients leads to cortisol release [81] . Allergen challenge induces the release of endogenous glucocorticoids from the adrenal, and even though in this context there is no doubt that IL-5 is released [48, 81] , thereby allowing glucocorticoids to potentiate its effects, a number of blanks remain in the mechanism through which local allergen challenge leads to release of adrenal glucocorticoids. We are currently evaluating whether local allergen challenge releases proinflammatory cytokines, such as TNF, that activate the Hypothalamus-Pituitary-Adrenal axis through central mechanisms. On the other hand, defining the link between release of stress hormones and increased eosinophilopoiesis is an important, unsettled issue. The cellular mechanisms that would account for the greatly increased frequency of committed eosinophil progenitors, at a surprisingly short time after challenge or surgery, have not been defined. Because of the clonal nature of commitment, candidate immunoendocrine mechanisms should in principle be able to change the fate of individual cells within the bone-marrow, thereby increasing the frequency of commitment into a particular minority lineage. Even though we have detected several effects on cellular pathways that might affect the proliferation, survival and terminal differentiation of cells in the lineage, we still cannot point out one particular glucocorticoid effect that explains why the bone-marrow of challenged, allergic animals contains an increased number of committed eosinophil progenitors, along with more precursors and mature eosinophils.
FROM SYSTEMIC REGULATION TO LOCAL MECHANISM: CAN WE ACCOUNT FOR THE EFFECT OF IMMUNOENDOCRINE MEDIATORS ON BONE-MARROW CELLS?
Some light on the local mechanisms regulating eosinophilopoiesis was shed by studies of the effects of cyclooxygenase (COX) inhibitors in bone-marrow culture. Indomethacin and aspirin enhanced IL-5-driven eosinophilopoiesis in culture [82] . This was accompanied by enhancement of GM-CSF-driven colony formation in agar, which may equally have an enhancing effect on eosinophilopoiesis, as lineage-committed progenitors are included in the target population. Because PgE2 had been shown to strongly inhibit eosinophilopoiesis in the same conditions [75] , through its ability to induce apoptosis in developing eosinophils [74] (see above), the simplest interpretation would be to attribute the effects of COX inhibitors to the blockade of endogenous PgE2 production. However, a number of observations suggest that the mechanisms involved are more complex than originally thought. Foremost was the observation that the enhancing effects of both drugs were lost if the bone-marrow came from sensitized mice [82] . While this finding is simple to describe, it is very difficult to explain, for it amounts to demonstrating that the effects of a drug may be radically changed by allergen sensitization of the host. This is not only hard to account for in terms of mechanism, it also goes against everyday reasoning in drug development and therapy. Decisions on whether or not to employ a drug are affected by a large number of considerations, including the possibility of sensitization to the drug, either before or after administration; but not, to our knowledge, by the possibility of sensitization to an unrelated antigen.
From a conceptual point of view, however, immunoregulation of drug responses is neither impossible nor far-fetched: one should remember that the target of the drug may be a cell of the immune system, and that the state of the immune system, by definition, changes over time as a consequence of its contact with antigen. Very complex changes do take place in the immune system after sensitization, which include activation, inactivation or deletion of cellular subpopulations, among which may be the particular cell type which is the target of the relevant drug action. If that specific target is inactivated or deleted as a result of sensitization, the corresponding drug response may become undetectable. The idea may not come naturally to some, because there is a widespread belief that antigens only exert antigen-specific effects on the immune system. This is not true, however: in the presence of specific antigen, T cell clones secrete cytokines, which (by definition) cannot be antigen-specific, and transduce the effects of antigendependent stimulation into targets that are themselves unresponsive to antigen, thereby adding nonspecific components to a specific response.
Sensitization was shown to affect the function of adherent cells from bone-marrow (presumably macrophages), in experiments in which responses to indomethacin were restored by mixing nonadherent cells from sensitized donors (which include eosinophil precursors, responsive to IL-5 but not to indomethacin) with adherent cells from nonsensitized donors (which do not include eosinophil precursors, and do not respond to IL-5). By contrast, the adherent cells from sensitized bone-marrow could not restore response to indomethacin. The evidence for adherent cells as a target for immunoregulation of drug responses is compatible with what is known of bonemarrow macrophages in terms of production of PgE2 [83] .
However, an alternative mechanism of action for indomethacin in this system has been suggested in experiments with a number of drugs that inhibit either the production or the effects of arachidonate derivatives. The inhibitors of 5-lipoxygenase activating protein (FLAP), MK886, and of the Cys-LT type 1 receptor, MK571 and Montelukast, did not, by themselves, affect the responses to IL-5 in bone-marrow culture. They did, however, block the responses to both COX inhibitors. On the other hand, Cys-LT, and especially LTD4, strongly potentiated responses to IL-5 in murine bone-marrow, in a way consistent with reports of their effects on eosinophil colony formation in humans [84] ; as expected, their effects were not affected by MK886, but were thoroughly blocked by MK 571 and Montelukast.
These observations suggest that COX inhibitors act through the generation of Cys-LT in the cultures, and that Cys-LT are the real enhancers of eosinopoiesis. Such situation has some similarities with a mechanism which has been proposed to account for aspirin-sensitive asthma, in which significant production of Cys-LT would occur in the presence of aspirin, but not in its absence [85] . This phenomenon would depend on the constitutive release of arachidonate at low rates and on its consumption through COX-dependent pathways, with its accumulation becoming noticeable only when all COX activity is blocked, up to levels sufficient to generate clinically significant amounts of Cys-LT. The mechanism relies on a number of prequisites, including the constitutive release of arachidonate and some degree of constitutive activity of the 5-lipoxygenase and LTC4 synthase enzymes.
Obtaining evidence that a similar shunting mechanism is operative in murine bone-marrow culture, and defining whether generation of Cys-LT in bone-marrow culture involves the activity of single cells or cooperation between different cell types leading to transcellular synthesis [86] , remains an important goal for the future, because it could possibly point a way towards the mechanism of immunoregulation of drug responses. For instance, our findings would make more physiological sense if one could demonstrate that sensitization upregulates the expression (or activities) of the enzymes responsible for LTC4 synthesis, thereby rendering superfluous the boost provided by COX inhibitors.
A further reason for exploring the biochemical mechanisms in this situation is the potential of Cys-LT for locally transducing systemic influences. Inhibition of Cys-LT production prevented the enhancing effects of allergen exposure on bone-marrow eosinophilopoiesis in humans [64] . Although glucocorticoids are believed to induce the expression of Annexin I, leading to inhibition of phospholipase A2, the major arachidonate-releasing enzyme [72] , recent studies have shown that leukotriene synthesis, at least in humans, is considerably less sensitive to glucocorticoid inhibition than anticipated. Furthermore, a number of studies have described glucocorticoid effects that have been termed counterintuitive, for they apparently lead to enhanced leukotriene synthesis, by promoting some of its key steps [72] . It is therefore possible that enhancement of leukotriene production by glucocorticoids, through increased expression or activity of the required enzymatic machinery, occurs in at least some of the experimental settings described here. If so, this might reconcile the observations that enhancement of eosinophilopoiesis by allergen challenge is blocked by Cys-LT type 1 receptor antagonists (in humans) and by RU486 pretreatment (in mice). Cys-LT are very important in many aspects of eosinophil biology: a) IL-5 is an important stimulus for Cys-LT production [72] ; b) some of the effects of eotaxin are dependent on Cys-LT production [72] ; c) Cys-LT production is essential for the tissue changes in which eosinophils have been shown to play their most important pathophysiological role -airway remodelling [87, 88] . It is now clear that Cys-LT are not only important in themselves; indeed, it is their far-reaching connectedness that underlies the surprising efficacy of treatments targeting Cys-LT in the management of asthma [72, 89] . The evidence discussed above suggests that this connectedness extends to the mechanisms of modulation of eosinophilopoiesis by allergen, drugs and stress reactions.
BEYOND INJURY: HOW ALLERGEN CHALLENGE PROMOTES COLONIZATION OF THE LUNGS BY EOSINOPHIL PROGENITORS
A number of recent studies show that another subset of hemopoietic cells, located outside the bone-marrow, also takes part in the integrated response to allergen exposure. We have been able to demonstrate the accumulation of hemopoietic progenitors in the lungs of ovalbumin-sensitized and challenged BALB/c mice [69] .
These cells were almost exclusively eosinophil lineagecommitted progenitors. Their growth requirements and their growth kinetics differed from those of bone-marrow progenitors isolated from bone-marrow of the same animals. Liquid culture of hemopoietic cells from lung in the presence of IL-5 provided evidence of eosinophil differentiation from precursors. These, however, were inhibited by dexamethasone, even at very low concentrations, in clear contrast with bone-marrow eosinophil precursors isolated from the same donors by the same procedure [90] . Importantly, IL-5, which can protect mature peripheral blood eosinophils from apoptosis induced by dexamethasone, was unable to protect lung eosinophil precursors.
Taken together, these findings indicate that the lungs of sensitized and challenged mice contain a distinct population of hemopoietic cells, which is absent in lungs from naive or from sensitized animals. This population is strongly biased towards eosinophil production, an observation that was more recently confirmed by others [91] , but differs from its counterpart in the bone-marrow by a number of functional criteria, especially pharmacological responses.
The emergence of this progenitor population only when sensitized animals were effectively challenged through the airways raises important questions, especially whether this is part of a nonspecific response to injury. This possibility would be consistent with: a) our previous findings on enhanced eosinophilopoiesis in mice submitted to surgical trauma [39] ; b) published observations of hemopoietic stem cell migration into sites of injury [92] [93] [94] ; c) evidence that bone-marrow cells migrate into injured lungs and contribute to pulmonary fibrosis [95] . To evaluate these issues, we have modified our experimental design in such a way that allergic injury to the lung tissue, if it occurred, would be completely dissociated from progenitor accumulation. The modified design we adopted was based on transplantation of lung tissue from a donor mouse into an ectopic site (the peritoneal cavity) of a recipient mouse, donor and recipient mice being submitted to a variety of sensitization and/or challenge protocols. The outcome of these manipulations was assessed, however, in the orthotopic site, that is, in the recipient`s lungs [96] .
It should be noted that, in this experimental design, accumulation of hemopoietic cells in the recipient's lungs would be expected only if it involves a systemic signal originating in the donor's lung tissue graft, rather than being a local phenomenon affecting the challenged lung tissue (i. e., the graft).
Furthermore, successful colonization of the recipient's lungs only in the presence of the appropriate donor graft (i.e., a graft from a sensitized and challenged donor) would not only exclude nonspecific injury as a significant factor, but reinforce the similarities between events taking place at the lungs and the bone-marrow of sensitized and challenged animals, for a systemic signal generated only by the appropriate sensitization and challenge protocol would be involved in both cases (see section 4). Both predictions were supported by our results. Colonization of the recipient's lungs by hemopoietic cells was observed when, and only when, the appropriate donor graft was implanted. Because the lungs where colonization was observed had not been exposed to allergen, it could not be explained by a nonspecific migration of hemopoietic stem cells and progenitors into sites of allergic injury. Because the effects of the appropriate graft could be exerted at a distance, it necessarily involved systemic signals. Such signals could not be carried out by nervous pathways, due to the lack of innervation of the graft. Hence, immunological and/or endocrine mediators must be responsible for the phenomenon. This experimental protocol made it possible to distinguish between the roles played by sensitization and by challenge. Colonization of the recipient's lungs occurred only when the recipient was sensitized (since the recipients were not challenged, no colonization could occur unless they received an ectopic graft). On the other hand, challenge had to be made in the donor through the airways, and using the same antigen used for sensitization, in order to generate an effective lung tissue graft. The double requirement for an appropriately sensitized and challenged donor and a sensitized recipient made colonization possible only in a specific donor-recipient combination.
We were able to demonstrate an important role for IL-5 in this model, by a number of criteria: a) grafts from the appropriate donors released biologically active IL-5, which induced eosinophilia in sensitized recipients; b) the effect of the appropriate donor-recipient combination was prevented by neutralizing anti-IL-5 antibody; c) grafts from unchallenged, sensitized donors synergized with recombinant IL-5 in sensitized recipients; d) grafts from IL-5 transgenic CBA/Ca mice (whose lungs contained a large number of progenitors, Fig. (2) . The interplay of factors regulating eosinophilopoiesis inside and outside the bone-marrow. The shaded areas represent hemopoietic compartments subject to regulation by environmental influences: 1, Systemic events occurring outside the respiratory system and bone-marrow (the skin and subcutaneous tissue, for sensitization and surgery); 2, events taking place in the respiratory system (challenge in the apherent phase, and eosinophil infiltration or progenitor colonization, in the efferent phase); 3, events taking place inside the bone-marrow. The unshaded area represents passage of cells and mediators through the circulation. Circles represent processes which influence these compartments through identifiable mediators (regulatory lymphocytes, IL-5, adrenal glucocorticoid hormones). Solid arrows indicate mechanisms for which direct evidence is available. Stippled arrows indicate mechanisms for which indirect evidence exists, from the literature or from our own studies as detailed in the text.
independently of sensitization and challenge) were effective in non-transgenic, ovalbumin-sensitized recipients, provided the latter were sensitized; unlike BALB/c donors, IL-5 transgenic donors needed no sensitization or challenge in order to generate effective lung tissue grafts.
Our interpretation of these observations is that allergen challenge in sensitized mice transforms lung tissue into a source of systemically acting signals, and IL-5 is one essential part of these signals. Most likely, other signals generated from the lung synergize with IL-5 in order to induce colonization of healthy lung tissue by hemopoietic cells. Although colonization might, in principle, be explained by expansion of some preexisting cell population found in naive lungs, this mechanism would not require a systemically acting signal; by contrast, systemic signalling is indispensable, if colonization is due to migration of circulating cells into challenged lungs.
These observations raise a number of questions for future study. Foremost, it matters to distinguish between a local expansion and a migration mechanism. As it has been shown that allergen challenge can lead to mobilization of hemopoietic cells from the bone-marrow [97] , this will involve designing modified protocols to demonstrate that properly tagged hemopoietic cells migrate from bone-marrow into the lungs following allergen challenge, and give rise to this specific progenitor population. Because IL-5 is released by the graft, not the orthotopic lung, it is unlikely to play a chemoattractant role. Instead, it may render cells in the bone-marrow competent to respond to a chemoattractant gradient originating in the lungs. Alternatively, migration may depend on the presence of the appropriate adhesion molecules in the pulmonary microcirculation, rather than on the buildup of a systemic chemoattractant gradient; if so, it is conceivable that the role of IL-5 is related to inducing the expression of such adhesion molecules in the orthotopic lungs.
BEYOND IL-5: DO WE KNOW ALL THERE IS TO KNOW ABOUT THE ROLE OF CELLULAR IMMUNITY IN EOSINOPHILOPOIESIS?
One of earliest and most consequential observations on eosinophilopoiesis was its critical dependence on cellular immunity [98] . Due to the central role of IL-5, the role played by T lymphocytes has been primarily regarded as providing a mobile, long-lived, adaptive source of IL-5. Interestingly, an increase in IL-5 producing cells was observed in bone-marrow of both mice [67] and rats [99] following allergen challenge in sensitized animals. In the latter model, migration of the IL-5-producing T lymphocytes from the airways into bone-marrow and other sites, depending on sensitization and challenge, was directly demonstrated [99] . Studies with other models of eosinophilia also showed accumulation of IL-5-producing T lymphocytes at sites of eosinophilopoiesis [100] . All these findings emphasize mobility of the IL-5 producers, obviating the need for reaching systemic levels of cytokines in order to link the challenge site to the bone-marrow.
More recently, however, other possibilities became apparent. While it is generally accepted that CD4+ T lymphocytes of the Th2 phenotype are the major source of IL-5 during adaptive immune responses, it has been shown that CD8+ cells would have an important regulatory role in a transgenic model where IL-5 was overexpressed by CD3+ cells (hence, by CD8+ cells as well as CD4+). CD8+ cells were shown by transfer into immunodeficient hosts (SCID-bg) to restore normal bonemarrow eosinophilopoiesis, raising the possibility that they play a hitherto unrecognized role in maintenance of steady-state eosinophil numbers. A role for CD8+ cells in allergenstimulated eosinophilopoiesis was equally suggested by bonemarrow eosinophil counts of sensitized transgenic mice overexpressing IL-5 but lacking either CD4+ or CD8+ T cells [102] . The exact role played by the IL-5-transgenic background in this model, however, remains to be determined, as the role of CD8+ T cells in eosinophilopoiesis has not yet been studied, to our knowledge, in nontransgenic mice.
Regulation by the so-called invariant natural killer (iNKT) cells, a small lymphocyte subpopulation with restricted specificity but potent immunoregulatory activities [103] provides another attractive possibility. Following activation by glycolipid and phospholipid ligands that are presented to them by the non-polymorphic, major histocompatibility complex class I-like molecule CD1d, they have been shown to secrete a variety of hemopoietic growth factors, and to influence hemopoiesis at multiple levels [103] . In particular, secretion of GM-CSF and IL-3 by iNKT cells has been taken as evidence of their involvement in the maintenance of steady-state hemopoiesis, even though there is strong evidence that these factors are dispensable for homeostasis in the healthy bonemarrow, at least in mice [31] . With respect to eosinophilia, iNKT cells may have a strong regulatory effect through secretion of IFN-γ [104] . It remains to be determined whether this plays a role in modulation of eosinophilopoiesis.
EMERGING PATTERNS: WHAT MODULATION STUDIES HAVE TOLD US SO FAR ABOUT EOSINOPHILOPOIESIS
In recent years, research focussing on hemopoietic cells (growth properties, cytokine receptor transduction mechanisms, transcription factor expression patterns) and that focussing on their environment (parasite infection or atopic background, allergen exposure and anti-allergic treatment) have converged to the point of highlighting major areas for future investigation. Firstly, there is a shift from regulation at the level of lineage-committed progenitors towards regulation at more advanced stages -with the practical consequence that the effects of regulation are felt sooner, as the regulation target and the effector, mature cell become closer. Secondly, there is dissociation between those mechanisms that depend on IL-5 (proliferation of committed cells, terminal differentiation and apoptosis of immature and mature eosinophils) and those that don't (the increase in lineage-committed progenitors). Finally, there is evidence that systemic events (allergen sensitization and challenge, surgical stress), through the release of adrenal glucocorticoids as well as by increased production of IL-5, impinge on both classes of mechanisms. As a result, the bonemarrow responds to these systemic events by exporting mature eosinophils, along with lineage-committed progenitors. Such an overview of the critical events is illustrated in Fig. (2) , which hopefully will convey some of beauty and complexity of the underlying mechanisms.
